The Need for Pediatric Drug Development

Authors

Robert M. Ward
Daniel K. Benjamin
Jonathan M. Davis
Richard L. Gorman
Ralph Kauffman
Gregory L. Kearns
Mary Dianne Murphy
Catherine M.T. Sherwin, Wright State UniversityFollow

Document Type

Article

Publication Date

1-2018

Abstract

Therapeutic tragedies in pediatric patients contributed to formulation of the legal requirement that new medications had to be carefully studied before they could be approved for interstate sale.¹ Despite this, the majority of pediatric patients who require treatment are prescribed medications that are either not approved for pediatric use or contain incomplete directions for pediatric use in the approved product label

Repository Citation

Ward, R. M., Benjamin, D. K., Davis, J. M., Gorman, R. L., Kauffman, R., Kearns, G. L., Murphy, M. D., & Sherwin, C. M. (2018). The Need for Pediatric Drug Development. The Journal of Pediatrics, 192, 13-21.
https://corescholar.libraries.wright.edu/pediatrics/185

DOI

10.1016/j.jpeds.2017.08.011